Investors Yank $255 Million From Biotech ETF

Updated on
  • SPDR S&P Biotech ETF saw $255 million outflow on Friday
  • Index of drugmakers has surged 19 percent over past 5 weeks

Once again, biotech is too hot to handle.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.